Columbia Financial, Inc. (CLBK) director Noel R. Holland reported an automatic acquisition of 127.7547 shares-equivalent of common stock on August 26, 2026, as phantom stock dividends under the Columbia Bank Stock Based Deferral Plan at a reference value of $11.62 per unit. Following this award, Holland holds 29,817.9802 indirect units in the deferral plan, 80,797 directly held common shares, 109,316 common shares indirectly through a SEP-IRA, and 6,494 common shares indirectly via Stock Award V. Holland also holds fully vested stock options covering 183,246 shares of common stock at an exercise price of $7.10 per share, expiring July 23, 2029.
Columbia Financial, Inc. (CLBK) reported that President & CEO Thomas J. Kemly indirectly acquired additional common stock on August 26, 2026 through exempt awards. He received 661.183 phantom-stock dividend units under a stock-based deferral plan and 392 dividend shares under the Savings Income Maintenance Plan, both referenced at $11.62 per share, increasing indirect plan holdings. The filing also lists his existing direct and indirect common stock and stock option positions, including multiple option grants under the 2019 Equity Incentive Plan with exercise prices between $7.10 and $8.31 per share.
Columbia Financial, Inc. (CLBK) reported that SEVP & Chief Risk Officer John Klimowich acquired additional indirect common stock interests on August 26, 2026 through exempt, plan-related awards. These included 88.059 phantom-stock dividend shares at $11.6200 per share under a stock-based deferral plan and 39.0000 shares at $11.6200 per share under a savings income maintenance plan. The filing also lists his existing direct and indirect common stock holdings across 401(k), ESOP, SERP and stock award vehicles, plus multiple stock option grants under the 2019 Equity Incentive Plan with exercise prices between $7.1000 and $8.3100 and significant remaining underlying shares.
Columbia Financial, Inc. (CLBK) reported that director Elizabeth E. Randall received a grant of 211.6385 phantom stock dividends on August 26, 2026, tied to Common Stock at a reference value of $11.62 per share under a stock-based deferral plan, held indirectly. Following this, her deferral-plan balance is 49,396.2812 common-share equivalents. She also reports 105,490 shares held directly, 97,783 by IRA, 26,968 by Roth IRA, 6,494 shares in a Stock Award V that vests on March 12, 2027, and fully vested stock options over 137,442 shares at an exercise price of $7.10 expiring July 23, 2029.
Columbia Financial, Inc. (CLBK) reported that director and officer Dennis E. Gibney received an exempt award of 18.4910 shares of Common Stock on August 26, 2026 at a reference value of $11.62 per share, recorded as phantom stock dividends under the Columbia Bank Stock Based Deferral Plan. Following this, he holds 4,315.8050 indirect shares in that deferral plan and 376,592 direct Common shares, plus additional indirect holdings through retirement plans and awards. He also holds multiple stock option grants under the 2019 Equity Incentive Plan with exercise prices between $7.10 and $8.31 per share and expirations from 2029 to 2036, all reported as holdings rather than new option transactions.
Columbia Financial, Inc. (CLBK) reported that SEVP & Chief Risk Officer John Klimowich received an award of 58.0679 shares of Common Stock on August 21, 2026 at $11.79 per share, credited as phantom stock in a stock-based deferral plan and reported as indirect ownership. Following this grant, his balance in the Stock-Based Deferral Plan is 20,522.7185 shares. He also reports direct holdings of 145,056 Common shares, additional indirect holdings through retirement and award plans, and multiple outstanding stock option positions with exercise prices between $7.10 and $8.31 per share.
Columbia Financial, Inc. (CLBK) reported that President & CEO Thomas J. Kemly received an award of 157.5649 shares of Common Stock on August 21, 2026 under a stock-based deferral plan, at a reference value of $11.79 per share. These are held indirectly through the Columbia Bank Stock Based Deferral Plan as phantom stock settled in shares, bringing that indirect plan-related holding to 153,816.4041 shares. The filing also lists Kemly’s existing direct and indirect Common Stock holdings and several outstanding stock option grants with exercise prices between $7.10 and $8.31 per share.
Columbia Financial, Inc. director Noel R. Holland reported an acquisition of 15.7214 shares of Common Stock equivalents on August 7, 2026, as a grant/award under a stock-based deferral plan at $10.84 per share. The footnotes explain this represents phantom stock purchased on a non-discretionary basis by the trustee of a rabbi trust under the Columbia Bank Stock Based Deferral Plan, to be settled in shares upon distribution. Following this award, indirect holdings in the deferral plan total 29,690.2255 stock units. Holland also reports 80,797 directly held Common Shares, 109,316 Common Shares held indirectly via a SEP-IRA, and 6,494 Common Shares held indirectly as Stock Awards that vest on March 12, 2027. In addition, fully vested stock options remain outstanding, covering 183,246 shares of Common Stock at an exercise price of $7.10 per share, expiring July 23, 2029.
Columbia Financial, Inc. executive John Klimowich, SEVP & Chief Risk Officer, reported an acquisition of 63.1568 shares of Columbia Financial common stock on August 7, 2026 at $10.84 per share. The shares represent phantom stock purchased on a non-discretionary basis in a rabbi trust under a stock-based deferral plan and will be settled in shares upon distribution.
Following this transaction, Klimowich holds 20,464.6506 indirect stock-based deferral units, along with various direct and indirect common stock holdings and multiple stock option awards with exercise prices between $7.10 and $8.31 per share.
Columbia Financial, Inc. President & CEO Thomas J. Kemly reported an award of 171.3736 units of Common Stock on August 7, 2026, at $10.84 per unit, credited as phantom stock under the Columbia Bank Stock Based Deferral Plan. This indirect position, held through a rabbi trust, increased his stock-based deferral plan balance to 153,658.8392 units. He also reports direct ownership of 588,391 shares of Common Stock and multiple indirect holdings through a 401(k), SERP, ESOP, spouse, and performance-based stock award vehicles, plus several option grants over Columbia Financial’s stock with exercise prices between $7.10 and $8.31 and expirations from 2029 to 2036.